Of note, and in line with our previous study on the contributions of PAR1 signaling to tumor cell state [36], we found that also in the absence of M0-CM inhibition of PAR1 (using Vorapaxar) resulted in an epithelial phenotype shift in cancer cells. The gene discussed is F2R; the disease is cancer.